NPCE Stock Analysis: Buy, Sell, or Hold?
NPCE - Neuropace, Inc. Common Stock
$15.36
-0.43 (-2.72%)
▼
5d:
-16.29%
30d:
-0.78%
90d:
+2.06%
WAIT
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 12, 2026
0d
Get Alerted When NPCE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: NPCE is down 16.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: NPCE is down 16.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: NPCE is currently trading at $15.36, which is considered slightly low relative to its 30-day fair value range of $15.28 to $17.51.
Technical Outlook: Technically, NPCE is showing sideways momentum. Immediate support is located at $13.65, while resistance sits at $19.60.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $19.88 (+29.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NPCE is showing sideways momentum. Immediate support is located at $13.65, while resistance sits at $19.60.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $19.88 (+29.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$15.28 -
$17.51
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 29.4% below Wall St target ($19.88)
- WARNING: Recommendation downgraded due to -16.3% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$15.28 -
$17.51
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$13.65
Resistance Level
$19.60
Current Trend
Sideways
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-38.38
Wall Street Target
$19.88
(+29.4%)
Revenue Growth (YoY)
-2.0%
Profit Margin
-21.7%
Share & Embed Analysis
Last updated: May 18, 2026 5:04 AM ET
Data refreshes hourly during market hours. Next update: 6:04 AM
Data refreshes hourly during market hours. Next update: 6:04 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NPCE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$83 | 66 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$389 | 58 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 55 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$250 | 59 HOLD |
